NMN for Malaysian Patients with Diabetes
With ~3.9M Malaysian adults having diabetes (IDF 2024 data), this is a meaningful population. NMN does NOT replace metformin or insulin therapy. The Yoshino 2021 trial showed muscle insulin signalling improvement at 250mg in prediabetic women - relevant context but not direct treatment evidence. Coordinate with your endocrinologist before starting; monitor HbA1c at every quarterly visit. Avoid abrupt addition during medication adjustment phases.
Key considerations
- Endocrinologist coordination
- HbA1c quarterly tracking
- Not a replacement for meds
- Hypoglycemia awareness
- Stable-medication-phase only
Use case guides
- Daily energy + fatigue
- Sleep quality
- Cognitive focus + memory
- Metabolic health (pre-diabetes, insulin sensitivity)
- Athletic recovery + performance
- Weight management + body composition
- Skin aging + photoaging
- Hair thinning + androgenic
- Immune resilience
- Longevity foundation
- Jet lag + travel recovery
- Post-COVID fatigue + long COVID
- Perimenopause + hormonal transition
- Sarcopenia + age-related muscle loss